{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:13:15Z","timestamp":1760919195353,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jceh.2020.04.004","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T22:14:09Z","timestamp":1587161649000},"page":"518-524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hepatocellular Carcinoma Screening and Nonalcoholic Fatty Liver Disease: How is it Different?"],"prefix":"10.1016","volume":"10","author":[{"given":"Subrat K.","family":"Acharya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sawan","family":"Bopanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2020.04.004_bib1","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/hep.26986","article-title":"Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients\u00a0with hepatocellular carcinoma in the U.S","volume":"59","author":"Wong","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2020.04.004_bib2","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.4254\/wjh.v7.i18.2155","article-title":"Advances in hepatocellular carcinoma: nonalcoholic steatohepatitis- related hepatocellular carcinoma","volume":"7","author":"Khan","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2020.04.004_bib3","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.510290347","article-title":"Cryptogenic cirrhosis: clinical characterization and\u00a0risk factors for underlying disease","volume":"29","author":"Caldwell","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2020.04.004_bib4","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1053\/jhep.2000.17894","article-title":"Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study","volume":"32","author":"Poonawala","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2020.04.004_bib5","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease","volume":"155","author":"Kanwal","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2020.04.004_bib6","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","author":"Younossi","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2020.04.004_bib7","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.cgh.2014.08.013","article-title":"Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population","volume":"13","author":"Mittal","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2020.04.004_bib8","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00535-014-0973-8","article-title":"Clinical characteristics, treatment, and prognosis of non-B,non-C hepatocellular carcinoma: a large retrospective multicenter cohort study","volume":"50","author":"Tateishi","year":"2015","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jceh.2020.04.004_bib9","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/hep.26986","article-title":"Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients\u00a0with hepatocellular carcinoma in the US","volume":"59","author":"Wong","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2020.04.004_bib10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.6061\/clinics\/2013(03)OA02","article-title":"Etiology of liver cirrhosis in Brazil: chronic alcoholism and hepatitis viruses in liver cirrhosis diagnosed in the state of Esp\u00edrito Santo","volume":"68","author":"Gon\u00e7alves","year":"2013","journal-title":"Clinics (Sao Paulo)."},{"key":"10.1016\/j.jceh.2020.04.004_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mayocp.2011.07.001","article-title":"Hepatocellular carcinoma in olmsted county,Minnesota, 1976-2008","volume":"87","author":"Yang","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jceh.2020.04.004_bib12","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1007\/s00535-011-0431-9","article-title":"Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey","volume":"46","author":"Tokushige","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jceh.2020.04.004_bib13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00508-011-0033-9","article-title":"Clinical characteristics of patients with hepatocellular carcinoma in Austria -is there a need for a structured screening program?","volume":"123","author":"Hucke","year":"2011","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.jceh.2020.04.004_bib14","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s00535-009-0112-0","article-title":"Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis","volume":"44","author":"Kawada","year":"2009","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jceh.2020.04.004_bib15","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.cgh.2009.02.025","article-title":"Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma","volume":"7","author":"Malik","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2020.04.004_bib16","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.5858\/132.11.1761","article-title":"Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?","volume":"132","author":"Guzman","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jceh.2020.04.004_bib17","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/hep.1840360609","article-title":"NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States","volume":"36","author":"Marrero","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2020.04.004_bib18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/gast.2002.34168","article-title":"Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma","volume":"123","author":"Bugianesi","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2020.04.004_bib19","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.22734","article-title":"Hepatocellular carcinomas in\u00a0patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis","volume":"49","author":"Paradis","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2020.04.004_bib20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2015.07.019","article-title":"Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease","volume":"14","author":"Mittal","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2020.04.004_bib21","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/ijc.25797","article-title":"Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis","volume":"128","author":"Ertle","year":"2011","journal-title":"Int J Canc"},{"key":"10.1016\/j.jceh.2020.04.004_bib22","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/liv.14087","article-title":"Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis","volume":"39","author":"Bengtsson","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2020.04.004_bib23","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/apt.15464","article-title":"Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study","volume":"50","author":"Gawrieh","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2020.04.004_bib24","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s12072-015-9679-0","article-title":"Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis","volume":"10","author":"Mohamad","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2020.04.004_bib25","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1007\/s10620-015-3821-7","article-title":"Hepatocellular carcinoma in the setting of non-cirrhotic nonalcoholic fatty liver disease and the metabolic syndrome: US experience","volume":"60","author":"Perumpail","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2020.04.004_bib26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2013.08.011","article-title":"Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team","volume":"60","author":"Dyson","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.04.004_bib27","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cgh.2011.01.023","article-title":"Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma","volume":"9","author":"Yasui","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2020.04.004_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001624","article-title":"Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis","volume":"11","author":"Singal","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.jceh.2020.04.004_bib29","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2020.04.004_bib30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Electronic address:easloffice@easloffice.eu; European association for the study of the liver. EASL clinical Practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.04.004_bib31","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0140-6736(14)60892-8","article-title":"Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5_24 million UK adults","volume":"384","author":"Bhaskaran","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2020.04.004_bib32","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1001\/archinte.166.17.1871","article-title":"Diabetes mellitus and the risk of cancer: results from a large-scale population based cohort study in Japan","volume":"166","author":"Inoue","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jceh.2020.04.004_bib33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cgh.2005.12.007","article-title":"The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence","volume":"4","author":"El-Serag","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2020.04.004_bib34","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ijc.27645","article-title":"Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort","volume":"132","author":"Schlesinger","year":"2013","journal-title":"Int J Canc"},{"key":"10.1016\/j.jceh.2020.04.004_bib35","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/bjc.2012.492","article-title":"Metabolic syndrome and hepatocellular carcinoma risk","volume":"108","author":"Turati","year":"2013","journal-title":"Br J Canc"},{"key":"10.1016\/j.jceh.2020.04.004_bib36","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/hep.24283","article-title":"Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease","volume":"53","author":"Sookoian","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2020.04.004_bib37","doi-asserted-by":"crossref","first-page":"12945","DOI":"10.3748\/wjg.v20.i36.12945","article-title":"Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors","volume":"20","author":"Dongiovanni","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2020.04.004_bib38","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/cam4.1078","article-title":"Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease","volume":"6","author":"Donati","year":"2017","journal-title":"Canc Med"},{"key":"10.1016\/j.jceh.2020.04.004_bib39","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1159\/000438473","article-title":"Non-alcoholic steatohepatitis-related hepatocellular carcinoma: a growing epidemic?","volume":"33","author":"Yopp","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.jceh.2020.04.004_bib40","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/hep.28368","article-title":"HCC-NAFLD Italian Study Group Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study","volume":"63","author":"Piscaglia","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2020.04.004_bib41","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.cgh.2014.08.013","article-title":"Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the Veteran\u00a0Affairs Population","volume":"13","author":"Mittal","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2020.04.004_bib42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00043426-199205000-00005","article-title":"Epidemiologic approach for cancer screening. Problems in design and analysis of trials","volume":"14","author":"Prorok","year":"1992","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jceh.2020.04.004_bib43","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3748\/wjg.v21.i4.1189","article-title":"Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease","volume":"21","author":"Leung","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2020.04.004_bib44","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ajg.2011.327","article-title":"Largescale long-term follow-up study of Japanese patients with non-alcoholicFatty liver disease for the onset of hepatocellular carcinoma","volume":"107","author":"Kawamura","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2020.04.004_bib45","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/jnci\/djs372","article-title":"Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases","volume":"104","author":"Wen","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jceh.2020.04.004_bib46","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1210\/jc.2012-1267","article-title":"Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"97","author":"Zhang","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jceh.2020.04.004_bib47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/00365521.2012.719926","article-title":"Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis","volume":"48","author":"Zhang","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2020.04.004_bib48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2012.10.005","article-title":"Statins are\u00a0associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis","volume":"144","author":"Singh","year":"2013","journal-title":"Gastroenterology"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688320300311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688320300311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:05:51Z","timestamp":1760853951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688320300311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0973688320300311"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2020.04.004","relation":{},"ISSN":["0973-6883"],"issn-type":[{"type":"print","value":"0973-6883"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocellular Carcinoma Screening and Nonalcoholic Fatty Liver Disease: How is it Different?","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2020.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}